Actively Recruiting
The Prognostic Value of Blood Biomarkers for Patients With Polyneuropathy
Led by Rigshospitalet, Denmark · Updated on 2024-04-11
200
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying the use of blood biomarkers to predict the progression of polyneuropathy, a condition affecting the nerves. This observational prospective cohort study aims to understand how biomarkers measured at the start relate to disease severity over two years. The study is led by Rigshospitalet, Denmark, and involves 200 patients diagnosed with polyneuropathy. Participants will undergo physical tests, medical examinations, questionnaires, and blood biomarker assessments at the beginning of the study, then again at 1-year and 2-year follow-ups. The investigators will analyze how baseline biomarker levels and physical test results predict disease progression using statistical methods. During the study, participants will attend three assessment visits over two years where various tests and questionnaires will be completed. The main outcome measured is disease severity at 2 years, along with patient-reported outcomes. The study will also evaluate the accuracy of biomarkers and physical tests in forecasting disease progression.
CONDITIONS
Brief Title
Prognostic Value of Biomarkers in Polyneuropathy.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Minimum 18 years old
- Diagnosed with polyneuropathy, confirmed by nerve conduction study
- Can read and understand Danish
You will not qualify if you...
- Inability to perform physical tests due to comorbidity not related to polyneuropathy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Baseline visit
Participants undergo physical tests, medical examination, questionnaires, and blood biomarker assessments to evaluate their polyneuropathy status.
1 visit (in-person)
Duration - 2 years
Participants are followed up with repeated assessments including physical tests, questionnaires, and blood biomarker evaluations to monitor disease progression.
2 visits (at 1 year and 2 years, in-person)
Trial Site Locations
Total: 1 location
1
Copenhagen Neuromuscular Center, Department of Neurology, Rigshospitalet
Copenhagen, Denmark, 2100
Actively Recruiting
Research Team
T
Tina Dysgaard, Dr.med.
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here